EP1507813A4 - Fat binding using inter-polymer complex of glucosamine and polyacrylic acid - Google Patents

Fat binding using inter-polymer complex of glucosamine and polyacrylic acid

Info

Publication number
EP1507813A4
EP1507813A4 EP03752869A EP03752869A EP1507813A4 EP 1507813 A4 EP1507813 A4 EP 1507813A4 EP 03752869 A EP03752869 A EP 03752869A EP 03752869 A EP03752869 A EP 03752869A EP 1507813 A4 EP1507813 A4 EP 1507813A4
Authority
EP
European Patent Office
Prior art keywords
glucosamine
inter
polyacrylic acid
polymer complex
fat binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03752869A
Other languages
German (de)
French (fr)
Other versions
EP1507813A1 (en
Inventor
Gour Mukherji
Clive Wilson
Ashok Rampal
Ravikumar Nithiyanandam
Mahendra R Joshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2002/001708 external-priority patent/WO2003068843A1/en
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of EP1507813A1 publication Critical patent/EP1507813A1/en
Publication of EP1507813A4 publication Critical patent/EP1507813A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/78Polymers containing oxygen of acrylic acid or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP03752869A 2002-05-20 2003-03-07 Fat binding using inter-polymer complex of glucosamine and polyacrylic acid Withdrawn EP1507813A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/IB02/01708 2002-05-20
PCT/IB2002/001708 WO2003068843A1 (en) 2002-02-12 2002-05-20 Glucosamine-polyacrylate inter-polymer complex and applications thereof
PCT/IB2003/000845 WO2003097714A1 (en) 2002-05-20 2003-03-07 Fat binding using inter-polymer complex of glucosamine and polyacrylic acid

Publications (2)

Publication Number Publication Date
EP1507813A1 EP1507813A1 (en) 2005-02-23
EP1507813A4 true EP1507813A4 (en) 2005-11-23

Family

ID=29434049

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03752869A Withdrawn EP1507813A4 (en) 2002-05-20 2003-03-07 Fat binding using inter-polymer complex of glucosamine and polyacrylic acid

Country Status (3)

Country Link
EP (1) EP1507813A4 (en)
AU (1) AU2003269702A1 (en)
WO (1) WO2003097714A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
WO2005030173A1 (en) * 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited Colon-specific drug delivery using interpolymer complexations
JP5221343B2 (en) 2005-06-17 2013-06-26 バイタル ヘルス サイエンシズ プロプライアタリー リミティド Carrier
WO2008067573A2 (en) * 2006-12-01 2008-06-05 Tshwane University Of Technology Drug delivery system
EP2373344B1 (en) * 2008-12-08 2016-03-30 F. Hoffmann-La Roche AG Combined drug administration
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
EP2552486B1 (en) 2010-03-30 2020-08-12 Phosphagenics Limited Transdermal delivery patch
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
WO2017096427A1 (en) 2015-12-09 2017-06-15 Phosphagenics Limited Pharmaceutical formulation
CN105520947B (en) * 2015-12-24 2018-05-01 广东药科大学 A kind of pharmaceutical composition with weight losing function containing Glucosamine
KR101882820B1 (en) * 2015-12-30 2018-07-30 주식회사 삼양바이오팜 Mucoadhesive pharmaceutical composition and preparation method thereof
EP3558903A4 (en) 2016-12-21 2019-11-27 Avecho Biotechnology Limited Process

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440541A (en) * 1982-05-20 1984-04-03 Polaroid Corporation Polarizer: dichroic dye in oriented polyacrylic acid/chitosan complex sheet
WO2003067952A2 (en) * 2002-02-12 2003-08-21 Ranbaxy Laboratories Limited Glucosamine-polyacrylate inter-polymer complex and applications thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447562A (en) * 1981-07-15 1984-05-08 Ivani Edward J Amino-polysaccharides and copolymers thereof for contact lenses and ophthalmic compositions
US4501835A (en) * 1982-03-08 1985-02-26 Polaroid Corporation Polyacrylic acid/chitosan polyelectrolyte complex
JPH0733682A (en) * 1993-07-26 1995-02-03 Shiseido Co Ltd Novel composite material and sustained-release preparation in which the same material is used as carrier
US5578661A (en) * 1994-03-31 1996-11-26 Nepera, Inc. Gel forming system for use as wound dressings
US6060410A (en) * 1998-04-22 2000-05-09 Gillberg-Laforce; Gunilla Elsa Coating of a hydrophobic polymer substrate with a nonstoichiometric polyelectrolyte complex
US6517933B1 (en) * 2000-01-18 2003-02-11 Nano-Tex, Llc Hybrid polymer materials

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440541A (en) * 1982-05-20 1984-04-03 Polaroid Corporation Polarizer: dichroic dye in oriented polyacrylic acid/chitosan complex sheet
WO2003067952A2 (en) * 2002-02-12 2003-08-21 Ranbaxy Laboratories Limited Glucosamine-polyacrylate inter-polymer complex and applications thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03097714A1 *

Also Published As

Publication number Publication date
WO2003097714A1 (en) 2003-11-27
EP1507813A1 (en) 2005-02-23
AU2003269702A1 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
AU2003259735A8 (en) Small-mer compositions and methods of use
IL164664A0 (en) Oligonucleotide compositions and their use for themodulation of immune responses
SI1379739T1 (en) Construction kit consisting of panel-shaped elements and connecting elements
IL165910A0 (en) Compositions of hyaluronic acid and methods of use
IL166780A0 (en) Use of ikappab-kinase inhibitors in pain therapy
EP1539003A4 (en) Microdermabrasion composition and kit
IL166608A0 (en) Anti-microbial compositions and methods of using same
AU2003287443A8 (en) Compositions and methods for pain reduction
AU2003299088A8 (en) Nocturnal muscle enhancing composition and method
AU2003299441A8 (en) Nf-hev compositions and methods of use
EP1507813A4 (en) Fat binding using inter-polymer complex of glucosamine and polyacrylic acid
EP1550694A4 (en) Acrylic rubber composition and crosslinked object
GB0219568D0 (en) Improvements in and to compositions
AU2003213120A8 (en) Human rnase iii and compositions and uses thereof
EP1549324A4 (en) Composition and method to whiten skin
EP1688126A4 (en) Parakeratosis inhibitor and external composition for skin
GB0615918D0 (en) Composition and its therapeutic use
GB0324523D0 (en) Compositions and methods of treatment
EP1601348A4 (en) Compositions and methods with enhanced therapeutic activity
SG110107A1 (en) Compound and use in treatment
AU2003282593A8 (en) Polyphenolamine composition and method of use
AU2003275433A8 (en) Compositions and methods for treating pain
AU2003293500A1 (en) Lactoferrin in the reduction of pain
AU2003296871A8 (en) Point feeder and use of point feeder
GB0327050D0 (en) Therapeutic methods compositions and uses

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041220

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20051011

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060530